CVR 37627186Entrepreneurial company (IVS)Konsulentbistand vedrørende informationsteknologi (620200)Vesterbrogade 26, 1620 København VFounded 14 Apr 2016
CINC Consult IVS
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about CINC Consult IVS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
0
CVR, 2017
Gross profit
-40.9K
DKK, annual report 2016
Result
-41.2K
DKK, annual report 2016
Equity
-38.2K
DKK, annual report 2016
Holding On ApSCVR 37561649, 25% to under 33.3% of capital and votes, until 27 Jun 2018
Baldero ApSCVR 32335624, 20% to under 25% of capital and votes, until 27 Jun 2018
and 2 moreJacob Kromann Lennhedenuntil 27 Jun 2018
Balder Haraldssønn Onarheimuntil 27 Jun 2018
Morten de Fine Friis-Olivariusuntil 27 Jun 2018
No current owner is registered.
CVR 3233562420% to under 25% of capital and votes14 Apr 2016 to 27 Jun 2018
CVR 3707476420% to under 25% of capital and votes14 Apr 2016 to 27 Jun 2018
CVR 3711554120% to under 25% of capital and votes14 Apr 2016 to 27 Jun 2018
CVR 3756164925% to under 33.3% of capital and votes14 Apr 2016 to 27 Jun 2018
CVR lists no current officers for this company.
Founded 14 Apr 2016.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Aug 2017, monthly: 2 employees, 2 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Jan 2017 | Feb 2017 | Mar 2017 | Apr 2017 | May 2017 | Jun 2017 | Jul 2017 | Aug 2017 |
|---|---|---|---|---|---|---|---|---|
| Employees | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| FTE | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group.
Source: CVR, latest Aug 2017, published 23 Oct 2017.
The company's own figures, in DKK, from the annual reports filed in XBRL.
| DKK thousands | 2016 |
|---|---|
| Gross profit | -41 |
| Operating profit | -45 |
| Result for the year | -41 |
| Equity | -38 |
| Total assets | 234 |
2016 covers 9 months (14 Apr to 31 Dec 2016).
Annual report 2016
14 Apr 2016 to 31 Dec 2016, published 31 May 2017
Amounts in DKK. Cash price is per DKK 1 of nominal capital, which a share split does not move.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| FoundingCashPaid in 90,000, cash price 30.00 | 30.00 | 90,000 | None | 3,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The company's own figures, in DKK, from the annual reports filed in XBRL.
| DKK thousands | 2016 |
|---|---|
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. |
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. |
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. |
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. |
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. |
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. |
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
Source: CVR, read 20 Nov 2026.
5 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Virksomheden er opløst ved erklæring, jf. selskabslovens § 216
Direktion:
Fratrådte:
Morten de Fine Friis-Olivarius, den 27.06.2018, Jacob Kromann Lennheden (adm. dir), den 27.06.2018, Balder Haraldssønn Onarheim, den 27.06.2018.
Ny adresse: c/o PlatoScience, Vesterbrogade 26, 1620 København V
Ny adresse: c/o Boks 42, UniVate, Njalsgade 76, 3., 2300 København S
Vedrørende registreringen den 20.04.2014 blev kapitalen offentliggjort til kr. 3.000,00 indbetalt kontant ved en fejl til kurs 3.000. Den korrekte kurs er 100.
Stiftelsesdato: 14.04.2016.
Virkningsdato: 14.04.2016.
Seneste vedtægtsdato: 14.04.2016.
Kapital:
kr. 3.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 3.000,00 til kurs 3.000,00, fuldt indbetalt.
Stiftere:
CVR-NR. 32335624 Baldero IVS, Struenseegade 49, 1. th., 2200 København N, den 14.04.2016, CVR-NR. 37074764 iCreate IVS, c/o Morten Friis-Olivarius, Ndr Engvej 1, 2791 Dragør, den 14.04.2016, CVR-NR. 37115541 COPENHAGEN INSTITUTE OF NEUROCREATIVITY IVS, c/o Balder Onarheim, Struenseegade 49, 2200 København N, den 14.04.2016, CVR-NR. 37561649 Holding On IVS, Vesterbo 33, 3500 Værløse, den 14.04.2016.
Direktion:
Morten de Fine Friis-Olivarius, den 14.04.2016, Jacob Kromann Lennheden (adm. dir), den 14.04.2016, Balder Haraldssønn Onarheim, den 14.04.2016.
Selskabet tegnes af en direktør..
Første regnskabsår:
14.04.2016 - 31.12.2016.
Regnskabsår:
01.01 - 31.12.
Formål:
1.2 Selskabets formål er at udbrede kendskabet til Neuro Creativity med henblik på at fremme kreativitet samt at opbygge en global organisation, der kan undervise og uddanne folk i videnskab og metoder til Neuro Creativity. Virksomhed, der efter ledelsens skøn er forbundet hermed er ligeledes omfattet af selskabets formål.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 20 Nov 2026.
What Pro holds for CINC Consult IVS:
Have Pro? Sign in.
P-number 1021353333Vesterbrogade 26, 1620 København V